AIE-pharmacology-enabled organelle therapeutics for microplastic-induced asthenozoospermia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42648265.
- Also identified by DOI 10.1016/j.biomaterials.2026.124569.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Microplastic pollution, particularly from polytetrafluoroethylene (PTFE), is an emerging threat to male fertility, driving spermatogenic impairment and asthenozoospermia through mitochondrial failure and ferroptosis-two interconnected pathologies that current therapies fail to address together. Herein, we introduce an "AIE-Pharmacology" strategy that transforms the natural product Hydroxysafflor Yellow A (HSYA) into a unique theranostic agent. We discover that HSYA possesses intrinsic aggregation-induced emission (AIE) properties, establishing a seamless "Drug-Probe Unity" wherein anti-ferroptotic pharmacology and self-reporting fluorescence are fused within a single molecule. Leveraging this attribute, we engineer living, functional mitochondria with HSYA to construct a bio-hybrid platform-Mito@H. This platform embodies a conceptual leap: mitochondria are no longer passive delivery vehicles but active therapeutic units that execute metabolic reprogramming by restoring NAD<sup>+</sup>/NADH redox balance and ATP synthesis, while the anchored HSYA concurrently suppresses ferroptosis via activation of the Nrf2/HO-1/SLC7A11/GPX4 axis. In a clinically relevant murine model of PTFE microplastic-induced asthenozoospermia, Mito@H administration strikingly rescues sperm count, progressive motility, and kinematic parameters, reconstitutes the complete spermatogenic lineage from spermatogonia to elongated spermatids, and reestablishes testicular redox homeostasis. This work pioneers a paradigm of organelle therapeutics powered by AIE-Pharmacology, offering a potent, precise, and translatable strategy to combat environmental toxicant-related male infertility and beyond.